Representative before the EPO

Employment test 11 - 50 employees
Company dna cabinet ores
operating since 1972
1131.04
Headquarter in Paris and 3 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 16 EP applications Dean Thomas has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after November 07, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12725512

AN ANTIOXIDANT COMPOSITION

IPC classification:
A61K 36/87, A61K 36/82, A61K 36/81, A61K 31/695, A61K 31/05
Agent:
Gevers
Agent:
Multiple attorneys, Cabinet Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12741386

ANTIBODIES THAT BIND TO OX40 AND THEIR USES

IPC classification:
A61K 39/395, C07K 16/28, A61P 37/06
Applicant:
Glenmark Pharmaceuticals SA
Agent:
Dean Thomas, Glenmark Pharmaceuticals SA
Agent:
Latscha Schöllhorn Partner AG
Status:
GRANT OF PATENT INTENDED
EP12735048

COMPOSITIONS FOR THE TREATMENT OF FRAGILE X SYNDROME

IPC classification:
A61K 31/404, A61P 25/28, A61P 25/00
Applicant:
University of Orléans (Université d'Orléans)
Applicant:
Centre Hospitalier Régional d'Orléans
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Gevers
Agent:
Lavoix
Agent:
Multiple attorneys, Cabinet Orès
Status:
GRANT OF PATENT INTENDED
EP12715261

NEW TALE-PROTEIN SCAFFOLDS AND USES THEREOF

IPC classification:
A61K 38/16, C12N 15/10, C12N 9/22
Applicant:
Cellectis SA
Agent:
Gevers
Agent:
Santarelli
Agent:
Multiple attorneys, Cabinet Orès
Status:
GRANT OF PATENT INTENDED
EP12816132

EXPRESSION CASSETTE

IPC classification:
C12N 15/09
Applicant:
Glenmark Pharmaceuticals SA
Agent:
Dean Thomas, Glenmark Pharmaceuticals SA
Agent:
Latscha Schöllhorn Partner AG
Status:
GRANT OF PATENT INTENDED
EP13766540

PURIFICATION OF HETERO-DIMERIC IMMUNOGLOBULINS

IPC classification:
C07K 16/46, B01D 15/38
Applicant:
Glenmark Pharmaceuticals SA
Agent:
Dean Thomas, Glenmark Pharmaceuticals SA
Agent:
Latscha Schöllhorn Partner AG
Status:
EXAMINATION IN PROGRESS
EP13808043

ANTI HER2 ANTIBODY FORMULATION

IPC classification:
A61K 39/395, C07K 16/32
Applicant:
Glenmark Pharmaceuticals SA
Agent:
Dean Thomas, Glenmark Pharmaceuticals SA
Agent:
Latscha Schöllhorn Partner AG
Status:
EXAMINATION IN PROGRESS
EP13811986

ANTIBODIES THAT BIND TO TL1A AND THEIR USES

IPC classification:
A61K 39/395, C07K 16/28, A61P 37/00
Applicant:
Glenmark Pharmaceuticals SA
Agent:
Dean Thomas, Glenmark Pharmaceuticals SA
Agent:
Latscha Schöllhorn Partner AG
Status:
The patent has been granted
EP14749786

EXPRESSION CONSTRUCTS AND METHODS FOR EXPRESSING POLYPEPTIDES IN EUKARYOTIC CELLS

IPC classification:
C12N 15/85, C12P 21/02, C07K 16/00
Applicant:
Glenmark Pharmaceuticals SA
Agent:
Dean Thomas, Glenmark Pharmaceuticals SA
Agent:
Latscha Schöllhorn Partner AG
Status:
GRANT OF PATENT INTENDED
EP14793557

PRODUCTION OF T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS

IPC classification:
B01D 15/38, C07K 16/46
Applicant:
Glenmark Pharmaceuticals SA
Agent:
Dean Thomas, Glenmark Pharmaceuticals SA
Agent:
Latscha Schöllhorn Partner AG
Status:
EXAMINATION REQUESTED
EP15707625

EXPRESSION CONSTRUCTS AND METHODS FOR SELECTING HOST CELLS EXPRESSING POLYPEPTIDES

IPC classification:
C12N 15/09
Applicant:
Glenmark Pharmaceuticals SA
Agent:
Dean Thomas, Glenmark Pharmaceuticals SA
Agent:
Latscha Schöllhorn Partner AG
Status:
EXAMINATION REQUESTED
EP15781677

ANTIBODIES THAT BIND TO CCR6 AND THEIR USES

IPC classification:
A61K 39/00, C07K 16/28
Applicant:
Glenmark Pharmaceuticals SA
Agent:
Dean Thomas, Glenmark Pharmaceuticals SA
Agent:
Latscha Schöllhorn Partner AG
Status:
Request for examination was made
EP15790129

CD3/CD38 T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS AND METHODS OF THEIR PRODUCTION

IPC classification:
A61K 39/395, C07K 16/28, C07K 16/46
Applicant:
Glenmark Pharmaceuticals SA
Agent:
Dean Thomas, Glenmark Pharmaceuticals SA
Agent:
Latscha Schöllhorn Partner AG
Status:
Request for examination was made
EP15720336

T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS

IPC classification:
C07K 16/40, C07K 16/28, B01D 15/38, C07K 16/46
Applicant:
Glenmark Pharmaceuticals SA
Agent:
Dean Thomas, Glenmark Pharmaceuticals SA
Agent:
Latscha Schöllhorn Partner AG
Status:
Request for examination was made
EP15807645

ANTI-TRKA ANTIBODIES WITH ENHANCED INHIBITORY PROPERTIES AND DERIVATIVES THEREOF FOR USE IN TREATING BONE ASSOCIATED PAIN

IPC classification:
A61P 29/00, A61K 39/395, C07K 16/28
Applicant:
Glenmark Pharmaceuticals SA
Agent:
Dean Thomas, Glenmark Pharmaceuticals SA
Agent:
Latscha Schöllhorn Partner AG
Status:
Request for examination was made
EP16206413

PRODUCTION OF T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS

IPC classification:
C07K 16/42, C07K 16/32, C07K 16/28, B01D 15/38, C07K 16/46
Applicant:
Glenmark Pharmaceuticals SA
Agent:
Latscha Schöllhorn Partner AG
Agent:
Dean Thomas, Glenmark Pharmaceuticals SA
Status:
Request for examination was made

Please Sign in to use this feature